ESGCT organises an Annual Congress, which brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. The Congress is typically held in October or November in a major European city. The Congress is a platform for highlighting the latest research and techniques through the scientific sessions, which include keynote lectures, invited speakers, selected speakers, poster sessions and exhibitions.
Furthermore, the Congress is an opportunity to develop relationships and collaborations. The public day, where key concepts in gene and cell therapy along with the latest research are presented in the local language to a general audience, is an integral part of the Congress. The Congress may be organised solely by ESGCT, but is often organised in collaboration with a national society for gene and cell therapy in Europe, for example the German Society for Gene Therapy (DG-GT) in 2017, or with closely related scientific societies, such as the International Society for Stem Cell Research (ISSCR) in 2016 and 2018. Information about this year's Congress can be found here. Please see our upcoming Congresses and have a look at previous Congresses too.
The objective of the European Society of Gene and Cell Therapy is the promotion of science and research.
One of the ESGCT’s core aims has always been to facilitate students’ access to key players and developments in the field. Hereto, ESGCT offers reduced congress registration rates for students, in addition to free society membership. To further this aim, supporting meetings and workshops aimed particularly at students is of particular interest to ESGCT.
...and so, the ESGCT Spring School was born!
The ESGCT Spring School is a 2 to 3-day meeting of presentations and workshops focused on students as the primary attendees. Students will have free registration to the meeting that includes all meals, and will only have to pay for their travel and accommodation.
This meeting is NOT a profit-making activity. The ESGCT will fully support this project financially , in addition to full use of the ESGCT Strategy & Events Team.
Please see the Upcoming Congresses page for more information about upcoming congresses and spring schools. Congress materials such as programmes, abstracts and video from the Education Day can all be found on the Previous Congresses and Spring Schools page.
CONGRESS RATES SHEET (PDF DOWNLOAD)
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!